These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36066271)

  • 41. Microcirculatory dysfunction in hypertrophic cardiomyopathy with chest pain assessed by angiography-derived microcirculatory resistance.
    Lu Y; Xue ZK; Gao W; Bai G; Zhang X; Chen KY; Li G
    Sci Rep; 2024 Jul; 14(1):16977. PubMed ID: 39043796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased circulating levels of malondialdehyde-modified low-density lipoprotein in patients with coronary microvascular dysfunction.
    Ito T; Yokoi M; Kitada S; Kawada Y; Mizoguchi T; Kikuchi S; Goto T; Seo Y
    J Clin Lipidol; 2024 Aug; ():. PubMed ID: 39278779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity.
    Chitturi KR; Bhogal S; Kassaian SE; Merdler I; Abusnina W; Chaturvedi A; Ben-Dor I; Waksman R; Case BC; Barac A; Hashim HD
    Cardiovasc Revasc Med; 2024 May; ():. PubMed ID: 38789343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial first pass perfusion assessed by cardiac magnetic resonance and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease.
    Mygind ND; Pena A; Mide Michelsen M; Ali Qayyum A; Frestad D; Emil Christensen T; Ali Ghotbi A; Hasbak P; Kjaer A; Vejlstrup N; Gustafsson I; Riis Hansen P; Steen Hansen H; Prescott E; Kastrup J
    Scand J Clin Lab Invest; 2019 Jul; 79(4):238-246. PubMed ID: 30889989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.
    Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y
    Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liang L; Wang X; Yu Y; Zhang Y; Liu J; Chen M; Zhang L; Jiang T
    Int J Gen Med; 2022; 15():4163-4173. PubMed ID: 35465304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility, safety and effectiveness in measuring microvascular resistance with regadenoson.
    Lachmann V; Heimann M; Jung C; Zeus T; Verde PE; Kelm M; Bönner F
    Clin Hemorheol Microcirc; 2019; 71(3):299-310. PubMed ID: 30103305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiography-based index of microcirculatory resistance (AccuIMR) for the assessment of microvascular dysfunction in acute coronary syndrome and chronic coronary syndrome.
    Fan Y; Li C; Hu Y; Hu X; Wang S; He J; Leng X; Xiang J; Lu Z
    Quant Imaging Med Surg; 2023 Jun; 13(6):3556-3568. PubMed ID: 37284070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve.
    Ng MK; Yeung AC; Fearon WF
    Circulation; 2006 May; 113(17):2054-61. PubMed ID: 16636168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between the Selvester QRS Score and Coronary Microvascular Dysfunction Assessed by the Index of Microcirculatory Resistance.
    Takeda A; Ikenaga H; Nakano T; Morita Y; Higashihara T; Watanabe N; Sada Y; Nakano Y
    Intern Med; 2023 Dec; 62(24):3591-3599. PubMed ID: 37121753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy.
    Malahfji M; Senapati A; Debs D; Angulo C; Zhan Y; Nagueh SF; Shah DJ
    Sci Rep; 2020 Sep; 10(1):15977. PubMed ID: 32994462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR.
    Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G
    Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve: insights from the International Index of Microcirculatory Resistance Registry.
    Lee JM; Layland J; Jung JH; Lee HJ; Echavarria-Pinto M; Watkins S; Yong AS; Doh JH; Nam CW; Shin ES; Koo BK; Ng MK; Escaned J; Fearon WF; Oldroyd KG
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002857. PubMed ID: 26499500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristic findings of microvascular dysfunction on coronary computed tomography angiography in patients with intermediate coronary stenosis.
    Hoshino M; Yang S; Sugiyama T; Zhang J; Kanaji Y; Hamaya R; Yamaguchi M; Hada M; Horie T; Nogami K; Ueno H; Misawa T; Yonetsu T; Hwang D; Lee JM; Shin ES; Doh JH; Nam CW; Koo BK; Sasano T; Kakuta T
    Eur Radiol; 2021 Dec; 31(12):9198-9210. PubMed ID: 34009414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
    Niida T; Murai T; Yonetsu T; Kanaji Y; Usui E; Matsuda J; Hoshino M; Araki M; Yamaguchi M; Hada M; Ichijyo S; Hamaya R; Kanno Y; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1077-1087. PubMed ID: 29516619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemodynamic and metabolic adaptations in coronary microvascular disease.
    Noaman S; Kaye DM; Nanayakkara S; Dart AM; Yong ASC; Ng M; Vizi D; Duffy SJ; Cox N; Chan W
    Heart; 2023 Jul; 109(15):1166-1174. PubMed ID: 36931716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incremental Value of Coronary Microcirculation Resistive Reserve Ratio in Predicting the Extent of Myocardial Infarction in Patients with STEMI. Insights from the Oxford Acute Myocardial Infarction (OxAMI) Study.
    Scarsini R; De Maria GL; Borlotti A; Kotronias RA; Langrish JP; Lucking AJ; Choudhury RP; Ferreira VM; Ribichini F; Channon KM; Kharbanda RK; Banning AP
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1148-1155. PubMed ID: 30797759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of Local Myocardial Damage on Index of Microcirculatory Resistance and Fractional Flow Reserve in Target and Nontarget Vascular Territories in a Porcine Microvascular Injury Model.
    Lee JM; Kim HK; Lim KS; Park JK; Choi KH; Park J; Hwang D; Rhee TM; Yang JH; Shin ES; Nam CW; Doh JH; Hahn JY; Koo BK; Jeong MH
    JACC Cardiovasc Interv; 2018 Apr; 11(8):717-724. PubMed ID: 29605246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
    Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
    Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.